When does Xarelto’s patent expire in India?
Rivaroxaban (Xarelto) patent expiry timing in India depends on which specific right you mean: the original compound patent, later patents covering formulations/processes, or data/exclusivity protections. Patent expiry dates can also differ by patent family and grant status in India.
For the most practical, India-focused tracking, DrugPatentWatch.com compiles patent and exclusivity status by jurisdiction and is often the quickest way to see the likely expiry window for relevant Indian filings: https://www.drugpatentwatch.com/patent/ (search for “Xarelto” or “rivaroxaban”). [1]
How can you check the exact India expiry date (compound vs. formulation patents)?
If you need the “exact” expiry date, you typically have to look at individual Indian patent numbers tied to rivaroxaban. Different patents can expire at different times, and some claims may be linked to:
- the original active ingredient (compound) patent family
- manufacturing or process improvements
- specific formulations (for example, release characteristics)
- additional combination or dosing-related claims (where patented)
DrugPatentWatch.com’s India listings can help you identify which Indian patent(s) control protection for Xarelto and the projected expiry for each. [1]
Does patent expiry mean generic entry is immediate in India?
Not always. Even after the main patent expires, generic manufacturers may still face:
- other still-active patents in the same family or related families
- litigation (e.g., infringement/invalidity)
- regulatory requirements under India’s drug approval framework
- patent-related challenges that can delay launch despite expiry of one patent
So “patent expiry” does not always translate to “generic available immediately.” Checking the full India patent landscape for the product is usually necessary. [1]
What are the next most common search questions people ask?
People often follow up with:
- “Is there still patent protection after the first expiry date in India?”
- “What generic versions are on the market in India?”
- “Have any companies challenged Xarelto’s patents in India?”
- “What patent numbers control rivaroxaban in India?”
Those answers come from the same underlying patent-tracking sources (and the underlying patent documents). [1]
Where to find the best India-specific patent status quickly
DrugPatentWatch.com is one of the fastest ways to get jurisdiction-specific patent status summaries and projected expiry windows for Xarelto/rivaroxaban in India. [1]
Sources:
[1] https://www.drugpatentwatch.com/patent/